Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 6.22B | 5.48B | 4.46B | 4.19B | 3.59B |
Gross Profit | 2.33B | 2.06B | 1.77B | 1.72B | 1.54B |
EBITDA | 702.13M | 688.92M | 539.18M | 483.34M | 525.23M |
Net Income | 286.21M | 340.35M | 240.74M | 203.33M | 181.85M |
Balance Sheet | |||||
Total Assets | 8.67B | 8.60B | 8.00B | 7.72B | 7.16B |
Cash, Cash Equivalents and Short-Term Investments | 4.18B | 3.84B | 4.34B | 4.28B | 4.21B |
Total Debt | 291.88M | 190.86M | 99.18M | 122.49M | 181.79M |
Total Liabilities | 2.32B | 2.29B | 1.96B | 1.97B | 1.36B |
Stockholders Equity | 6.22B | 6.20B | 5.93B | 5.75B | 5.81B |
Cash Flow | |||||
Free Cash Flow | 883.56M | -542.51M | 178.63M | 441.95M | 263.78M |
Operating Cash Flow | 933.79M | -240.22M | 391.70M | 586.09M | 408.83M |
Investing Cash Flow | -174.17M | -125.47M | -209.42M | -201.81M | -126.76M |
Financing Cash Flow | -427.62M | -47.77M | -122.28M | -320.48M | -177.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥6.90B | 16.98 | 1.10% | 11.52% | 35.61% | ||
76 Outperform | ¥10.14B | 28.23 | 0.52% | 24.77% | 116.47% | ||
76 Outperform | ¥7.52B | 26.39 | 1.81% | 13.55% | -14.28% | ||
74 Outperform | ¥7.67B | 9.16 | 3.55% | 18.10% | 17.97% | ||
72 Outperform | ¥6.88B | 11.13 | 1.85% | ― | ― | ||
71 Outperform | ¥8.54B | 12.78 | 3.40% | 1.91% | ― | ||
62 Neutral | £517.98M | 25.05 | -6.45% | 2.79% | 3.10% | -19.55% |